Evidence map›Paper›PMID 42606952›Full record

ArticleeLife2026

Probing relaxed myosin states in hypertrophic cardiomyopathy by second harmonic-generation microscopy.

Giulia Arecchi, Marica Dente, Weikang Ma, Beatrice Scellini, Nicoletta Piroddi, Marina Scardigli, Jingyuan Yu, Jing Zhao, Riccardo Cicchi, Ryo Kinegawa and 8 more

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Giulia ArecchiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID https://orcid.org/0009-0008-4506-9016
Marica DenteDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Weikang MaIllinois Institute of Technology, Chicago, United States.ORCID https://orcid.org/0000-0001-9535-7114
Beatrice ScelliniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Nicoletta PiroddiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Marina ScardigliDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Jingyuan YuCollege of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Jing ZhaoCollege of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Riccardo CicchiNational Institute of Optics (INO) - CNR, Florence, Italy.
Ryo KinegawaSchool of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom.
Caroline MuellenbroichSchool of Physics and Astronomy, University of Glasgow, Glasgow, United Kingdom.
Francesco SeraDepartment of Statistics, Computer Science and Applications "G. Parenti", University of Florence, Florence, Italy.
Corrado PoggesiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID https://orcid.org/0000-0003-2624-4778
Cecilia FerrantiniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Thomas C IrvingIllinois Institute of Technology, Chicago, United States.ORCID https://orcid.org/0000-0003-4848-3323
Michael RegnierSchool of Medicine and College of Engineering, University of Washington, Seattle, United States.ORCID https://orcid.org/0000-0001-5437-9851
Leonardo SacconiInstitute of Clinical Physiology (IFC) - CNR, Florence, Italy.ORCID https://orcid.org/0000-0002-9320-5085
Chiara TesiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID https://orcid.org/0000-0002-1111-1473

Funding

The Biophysics Collaborative Access Team (User Training and Outreach)P30GM138395 · NIGMS · ILLINOIS INSTITUTE OF TECHNOLOGY · PI THOMAS C IRVING · 2021 to 2026
$16.5M
UW Center for Translational Muscle Research (Overall Application)P30AR074990 · NIAMS · UNIVERSITY OF WASHINGTON · PI Jennifer Michelle Davis, DANIEL RAFTERY · 2019 to 2026
$7.5M
Engineered Stem Cells for Cardiac RepairR01HL128368 · NHLBI · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2018 to 2025
$6.1M
Computational and Experimental Models of Myosin VariantsR01HL179584 · NHLBI · UNIVERSITY OF WASHINGTON · PI Farid Moussavi-Harami, MICHAEL REGNIER · 2026 to 2026
$1.8M
Thick filament regulation mechanisms in healthy and diseased myocardiumR01HL171657 · NHLBI · ILLINOIS INSTITUTE OF TECHNOLOGY · PI Weikang Ma · 2024 to 2026
$1.3M
Horizon 2020 Framework Programme 10.3030/101137115Horizon 2020 Framework Programme 10.3030/952166Italian Ministry of University and Research PRIN2022 #2022F3NENHNational Heart Lung and Blood Institute HL179584National Heart Lung and Blood Institute R01 HL128368National Heart Lung and Blood Institute R01HL171657NextGenerationEU I-PHOQS InfrastructureNHLBI NIH HHS R01 HL128368NHLBI NIH HHS R01 HL171657NHLBI NIH HHS R01 HL179584NIAMS NIH HHS P30 AR074990NIGMS NIH HHS P30 GM138395
6 · The paper itself

Abstract

This study explores the use of polarized second-harmonic generation (pSHG) to investigate myosin conformation in the relaxed state, differentiating between the actin-available, disordered (ON) state and the energy-conserving, ordered (OFF) state. By shifting the ON/OFF equilibrium using both physical and chemical manipulations, we demonstrate the sensitivity of pSHG in quantifying the ON/OFF ratio in skeletal and cardiac tissues. Comparisons with X-ray diffraction measurements further validate our findings. Applying this approach to a sarcomeric mutation associated with hypertrophic cardiomyopathy, we show that R403Q/MYH7-mutated minipig ventricle tissue exhibits a higher ON fraction compared to controls. This difference is abolished under high concentrations of a myosin activator (2-deoxyATP) and an inhibitor (Mavacamten), indicating structural similarity between R403Q and controls in these two states. ATPase assays reveal increased resting ATPase activity in R403Q samples, which persists even in the presence of 2-deoxyATP, suggesting that the elevated energy consumption in the R403Q mutation is driven by both a population shift toward the ON state and enhanced myosin ATPase activity per motor head.

Indexed as

Cardiomyopathy, HypertrophicMicroscopyMyosinsAnimalsMutationProtein ConformationSwineMyosinslabel-free imagingminipigmolecular biophysicsmousephysiologyrabbitSRXstructural biologysuper-relaxed statethick filament regulation

Identifiers

PMID42606952
PMCPMC13480991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.